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INTRODUCTION: 
Carvedilol (CV) is a non-cardioselective alpha1- beta 
adrenergic blocking agent with no intrinsic 
sympathomimetic activity and weak membrane-stabilising 
activity. The alpha 1-adrenergic blocking activity of CV 
causes vasodilation and reduces peripheral vascular 
resistance. At higher doses calcium channel blocking 
activity also observed. CV is most effective in 
management of hypertension, in angina pectoris, heart 
failure, and left ventricular dysfunction with myocardial 
infarction. CV has a terminal half-life of 7-10 hr, but most 
of the drug is eliminated with a half-life of about 2 hr, and 
the recommended oral dose for adult is two times a day. 
CV has advantage over traditional β-blockers with respect 
to hemodynamic and metabolic effects. Such results 
indicate its safe and effective therapeutic application 
particularly in patients with complicated Cardiovascular 
Diseases (CVDs), even in paediatric and geriatric patients.1 
CV has narrow absorption window i.e. upper part of 
gastrointestinal tract (GIT).Therefore a good candidate for 
gastroretentive dosage form.2 
It is widely known that gastric residence time (GRT) is one 
of the important factors affecting the drug bioavailability 
of pharmaceutical dosage forms.3 Variable and short 
gastric emptying time can result in incomplete drug release 
from the dosage form (DF) above the absorption zone 
(stomach or upper part of small intestine), leading to a 
diminished efficacy of the administered dose.4 Though oral 
SR-DF have been developed due to their important 
therapeutic advantages, this approach has not been suitable 
for a variety of important drugs, characterized by a narrow 
absorption window in the upper part of the GIT.5 After 
only a short period of less than 6 h, the SR-DF has already 
left the upper gastrointestinal tract and the drug is released 
in nonabsorbing distal segments of the GIT.6 This results 
in a short absorption phase that is often accompanied by 
lesser bioavailability. Also SR-DF has limited advantage 
for locally active drugs in the stomach; those are unstable 
in the intestinal or colonic environment, and exhibit low 
solubility at high pH values.7 
These limits promoted the development of Gastro 
Retentive Dosage forms.  
Gastro Retentive Dosage forms that were designed in large 
part based on the following approaches: 
 Low density DF shows buoyancy above gastric fluid.8 
 High density DF retained in the bottom i.e. antrum of 
the stomach.
9
 
 Bioadhesion to the stomach mucosa.10 
 Slowed motility of the GIT by concomitant 
administration of drugs or pharmaceutical excipients 
or food agents like fatty acids.11 
 Expansion by swelling or unfolding to a large size 
which does not allow the DF to pass through the 
pyloric sphincter.12 
In case of oral drug delivery systems compressed 
hydrophilic matrices are commonly used because of their 
good compatibility. Drug release from hydrophilic matrix 
tablets is controlled by formation of a hydrated viscous 
layer around the tablet which acts as a barrier to drug 
release by opposing penetration of water into tablet and 
also movement of dissolved solutes out of the matrix 
tablets. The overall drug release process is influenced by 
drug solubility, physical and mechanical properties of the 
gel barrier that forms around the tablet. The extent of 
matrix swelling, erosion, and diffusion of drug determines 
the kinetics as well as the mechanism of drug release.13, 14, 
15 
ABSTRACT 
Gastroretentive dosage forms (GRDF) enable prolonged and continuous input of the drug to the upper parts of the 
gastrointestinal tract and improve the bioavailability of medications those are characterized by a narrow absorption window. 
The aim of this study was first to develop and physico-chemically characterize an optimal single unit bilayer floating tablet for 
Carvedilol phosphate (CP) prepared by direct compression technology secondly use Ocimum basilicum mucilage (OBM) as a 
gelling, swelling and sustaining polymer in combination with HPMC and compared their drug release profile with marketed 
sustained release formulation for once-a-day administration of Carvedilol. Effect of OBM and its concentration on tablet 
properties such as hardness, friability, floating characteristics, swelling properties, tablet erosion and release patterns were 
evaluated. The release rate and floating characteristics could effectively be modified by varying ‘‘matrix forming swelling 
polymer, gas-generating agent’’ ratio. Drug release in optimized formulation was approximately 93.80% in 24 h in vitro and 
floating lag time around 5 min. The results showed floating tablets are a feasible approach for the sustained release (SR) 
preparation of CP. 
Keywords: Gastroretentive, Bilayer floating, Carvedilol phosphate, HPMC, Ocimum basilicum mucilage. 
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OBM is studied for its rheology, binding properties and 
Disintegrant properties, but its use as a gelling, swelling 
and sustaining polymer is not yet studied therefore in this 
paper we have tried to use natural polymer i.e., OBM as a 
gelling, swelling and sustaining polymer in combination 
with HPMC and developed the sustaining formulation of 
CP by Gastro retentive technology to maintain the 
resultant buoyancy for duration of upto 22 h. This 
formulation of the matrix dosage form with two distinct 
layers allows separate regulation of the floating 
capabilities and drug release kinetics.  
MATERIALS AND METHODS: 
Materials: 
Carvedilol phosphate was gifted by Cipla Ltd., India. 
HPMC K100M and Microcrystalline cellulose (MCC) 
were obtained as gift samples from Colorcon Asia Pvt. 
Ltd., Mumbai. Magnesium stearate was gifted by Kopran 
Ltd., Khopoli. Sodium bicarbonate (Analytical grade) was 
purchased from Research lab fine chem. Industry. Basil 
seeds (Sabja, Ocimum basilicum L.) used in study were 
purchased from Ayurvedic medical store from local market 
at Mumbai, India. All other reagents were purchased from 
Merck Pvt. Ltd., India and were of analytical grade. All the 
studies were carried in distilled water. 
Authentification of Basil Seeds: 
Plant developed from the seeds purchased from local 
market and there after herbarium was made with plant and 
seeds sample. This sample was sent to the Botanical 
Survey of India, Pune. Authentification of sample was 
done by Scientist ‘C’ In-charge. 
Mucilage extraction from basil seeds: 
The extraction of gum from basil seeds was performed by 
modifying the method given in S.H. Hosseini-Parvar et al., 
2010.16 The basil seeds were soaked and swelled in 
distilled water at 68 ± 1 0C and a water/seed ratio of 65:1. 
The mixture was stirred with a mechanical stirrer (Remi 
motor, Remi Elektrotechnik Ltd.) until the seeds were 
completely swelled (4 hrs agitation, 500 rpm). The swelled 
seeds were passed through a high speed homogenizer at 
6000 rpm (Remi motor, Remi Elektrotechnik Ltd.) to 
separate the gum layer from the seed surface. Then the 
total mixture is squeezed manually by hand through (40#) 
muslin cloth so that seeds get separated from gum and then 
gum was washed with acetone to remove any soluble 
impurities. The precipitated OBM  separated, vacuum 
dried in vacuum oven (Lab Hosp, Mumbai; with vacuum 
pump of capacity 50Lt/min, vacuum 0.005 Torr, Atharva 
Vacuum Technologies Pvt. Ltd.) at 30-40 0c, powdered 
and passed through sieve (80#), then stored in tightly 
closed containers under dry and cool conditions. 
Spray drying of OBM: 
A Microcontroller Operated Unit – LU – 222 Advanced 
Lab Spray Dryer with pre-HEPA filter (Labultima, 
Mumbai, India), equipped with a co-current (to hot air 
flow) – 0.7 mm, fluid spray nozzle with Autojet 
Deblocking System having variable stroke interval 
controlled through microcontroller was used to dry the 
gum. Drying chamber consist of 6” Borosilicate glass with 
specific dimensions through which the gum solution was 
fed using peristaltic pump of capacity 1250 ml/hr with 
3mm internal diameter tube and having variable speed 
control. Various parameters selected for optimised batch 
were: Inlet air temperature (220 0c), Outlet air temperature 
(100 0c), Aspirator flow rate (45 Nm3/hr), Feed pump flow 
rate (8 ml/min), Atomisation rate of 2 – 3 bars. Distilled 
water at room temperature was used for preparing gum 
solution, start-up and shut down operations. 
pH determination of OBM  solution: 
0.1% OBM solution was used to determine the pH with 
calibrated Digital pH meter, model – EQ-610 (EQUIP - 
TRONICS). 100 ml solution was used to measure pH. 
Viscosity measurement of OBM: 
Viscosity measurements were carried out using Brookfield 
Viscometer [DV-II + Pro] in small sample adapter with 
spindle number 18 (Brookfield Engineering Labs. Inc.). 
Different concentrations of OBM were prepared by 
hydrating dried hydrocolloid powder in distilled water 
while stirring for 2 h using a mechanical stirrer. The 
dispersions were then left for sometime at 4 °C to ensure a 
complete hydration. For test, hydrated samples were 
loaded into the small sample adapter and allowed to 
equilibrate for 10 min at Room Temperature (RT) and 
were subjected to a programmed shear rate increasing from 
0.396 to 132 s−1. 
Determination Water absorption capacity (WAC): 
WAC was determined by modifying the method described 
by Sciarini et al. (2009).17 The gum (0.02 g) was 
completely wetted with distilled water in a test tube. Then 
test tube was centrifuged at 10000 rpm for 30 min, the 
supernatant discarded, and the swollen sample weighed. 
The WAC was calculated as: 
WAC = (ssw–sw) / sw 
Where, 
ssw = the swollen sample weight and 
sw = is initial sample weight taken (before wetting). 
Effect of pH on WAC: 
Same study was repeated by using 0.1N HCl and 0.1N 
NaOH instead of distilled water. 
Morphological analysis using Scanning Electron 
Microscope (SEM): 
The outer macroscopic structures of the samples were 
investigated by scanning electron microscope (Jeol JSM 
6360 A, Tokyo, Japan). The samples were fixed on a brass 
stub using double-sided adhesive tape and were made 
electrically conductive by coating of about 10 0A with 
platinum in Argon atmosphere using Hitachi Ion Sputter 
(E- 1010) for 5 min. The SEM images were analyzed with 
an image analysis system for particle size and 
morphological analysis. 
Drug - excipient compatibility study: 
The interaction was studied for prediction of stability and 
compatibility between drug and polymer which was 
analyzed by using IR spectroscopy and DSC study. 
Physical mixtures were prepared by triturating drug and 
excipients in mortar and kept in stability chamber at 45 0C 
± 2 0C/ 75% RH ± 5%RH for one week. After one week 
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samples were evaluated for interaction study by chemical 
analysis using IR and DSC studies. 
Preparation of single unit bilayer and floating matrix 
tablet: 
CP bilayer floating tablets were prepared by direct 
compression technology. Bilayer tablet contains two layers 
i.e. floating layer and sustained release layer.  
Table 1: Formulation Table 
Composition of Floating Layer 
 FORMULATION 
COMPOSITION/
Code 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16 
HPMC K100M 60 30 60 30 40 50 60 60 30 40 40 50 40 50 50 30 
SODIUM 
BICARBONATE 
30 50 20 40 40 30 50 40 30 30 20 50 50 20 40 20 
MAGNESIUM 
STEARATE 
0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
OCIMUM 
BASILICUM 
MUCILAGE  
59.
85 
69.
85 
69.
85 
79.
85 
69.
85 
69.
85 
39.
85 
49.
85 
89.
85 
79.
85 
89.
85 
49.
85 
59.
85 
79.
85 
59.
85 
99.8
5 
                 
Composition of Sustain release layer 
HPMC K100M 10 40 20 40 30 10 30 10 40 20 10 20 40 20 30 30 
OCIMUM 
BASILICUM 
MUCILAGE  
40 30 10 20 10 20 40 30 40 20 10 30 10 40 20 30 
CARVEDILOL 
PHOSPHATE 
40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 
MAGNESIUM 
STEARATE 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.1
5 
0.15 
MICROCRYSTA
LLINE 
CELLULOSE 
59.
85 
39.
85 
79.
85 
49.
85 
69.
85 
79.
85 
39.
85 
69.
85 
29.
85 
69.
85 
89.
85 
59.
85 
59.
85 
59.
85 
59.
85 
39.8
51 
All quantities mentioned are in mg 
As per given in formulation table 1, Floating layer contains varied proportion of hydrophilic polymers (HPMC K100M and 
OBM), gas generating agent (sodium bicarbonate)  and in sustained release layer amount of CP was kept constant at 40mg 
while the amount of other excipients i.e. HPMC K100M, OBM and MCC was varied. Magnesium stearate was used as 
lubricant in both layers. All ingredients were passed through sieve (40#) and mixed uniformly for 10-15 min in polythene 
bag. Weighed quantity of SR layer equivalent to 150mg was compressed at pressure of 0.5 ton for 30 seconds. Weighed 
quantity of floating layer equivalent to 150 mg was added on the slightly compressed SR layer and both the layers were 
compressed into the tablet using a manual KBr hydraulic press (PCi, India) with a die of 13.06 mm diameter flat punches 
at pressure of 3.5 tons for 30 seconds. 
Evaluation of powder blends (Precompression Parameters): 
Bulk density, tapped density, angle of repose, compressibility index (Carr’s Index), Hausner’s Ratio were evaluated as per 
standard procedures. 
Post Compression Parameters: 
Tablet Hardness: 
The hardness of tablet of each formulation was measured by Monsanto hardness tester. The hardness was measured in 
terms of kg/cm2. 
Friability of the tablets: 
For friability study twenty tablets of the formulation were weighed. Roche type friabilator was used for this study. The 
tablets were rotated at 25 rpm for 4min, and then dedusted it and reweighed. The percentage friability was calculated using 
the equation: 
F% = W1 – W2 / W1 × 100 
Where F% is the percentage weight loss, and  
W1 and W2 are the initial and final tablets weights, respectively. 
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Detachment Stress: 
The mucoadhesive forces of the bilayer tablets were 
determined by means of modified analytical two pan 
balance. The pieces of stomach (Fundus) tissue of goat 
were taken in saline solution to 370C before use. At the 
time of testing a section of tissue was attached, keeping the 
mucosal side out, on to upper glass vial. Vial with a 
section of tissue was connected to the pan balance and the 
other vial was fixed on a lower side, height to adjustable 
pan. To the lower vial, a bilayer tablet was applied with the 
help of double-sided adhesive tape. The height of the vial 
was adjusted so that the tablet could adhere to the mucosal 
tissues of upper vial. Weights were added at a constant rate 
to the pan on the other side of the modified balance of the 
used device until the tablet gets detached from tissue. The 
bioadhesive force, expressed as the detachment stress in 
dyne/cm2, was determined from the minimal weights 
required for the detachment using the following equation18: 
Detachment stress (dynes/cm2) = mg / A 
Where, 
m = the weight added to the balance in gram. 
g = acceleration due to gravity taken as 980 cm/sec2. 
A = area of tissue exposed and is equal to Πr2 
       (r-the radius of the tablet attached to tissue). 
The floating lag time and the total floating time: 
Floating behaviour studies were performed on both the 
floating layer and bilayer floating tablet, carried out in a 
USP Dissolution Testing Apparatus II (Paddle type) at 
paddle speed 50 rpm in 900ml 0.1 N HCl at 37 ± 0.2 °C 
for 24 hrs to mimic in vivo conditions. For determining the 
optimized floating lag time and total floating time of the 
delivery system, various formulations prepared as per table 
1 were studied. The time interval between the introduction 
of the tablet into the dissolution medium and its buoyancy 
to the top of dissolution medium was taken as floating lag 
time, the duration of system floatation and also the relative 
matrix integrity was observed visually. 
Swelling Characteristics: 
Swelling property of tablet was determined by placing it in 
the dissolution test apparatus, in 900 ml of 0.1 N HCL at 
37 ± 2 0C. The weight and volume reached by the matrix 
tablets over time was determined by withdrawing the 
tablets periodically from dissolution medium. The tablets 
were weighed on an analytical balance after slight blotting 
with tissue paper to remove the excess test liquid. The 
volume of the tablets was obtained by measuring the 
thickness and diameter, considering a right circular 
cylinder form. The determined weight and volume were 
used to calculate the tablet density over the dissolution 
study. Swelling characteristics were expressed in terms of 
percentage water uptake (WU %) according to the 
equation: 
WU % = Wt. of swollen tablet – Initial wt. of 
tablet / Initial wt. of tablet × 100 
Matrix tablets density and Resultant-weight 
determination: 
The magnitude and the direction of total force F 
correspond to the vectorial sum of the buoyancy (Fbuoyancy) 
and gravity (Fgravity) forces acting on the object. 
RW or F = Fbuoyancy – Fgravity = DfgV - DsgV = (Df 
- Ds) gV = (Df – M/V) gV 
Where, 
RW or F = total vertical force 
Df = fluid density 
Ds = object density 
M = object mass 
V = volume 
g = acceleration due to gravity 
The total force F acting vertically on an immersed object 
may be used to quantify the object floating or non-floating 
capabilities. A positive total force F signifies that the 
object is able to float, whereas a negative F means that the 
object sinks. The larger the total force F value of the 
object, the more excellent its floating capability.6 The 
medium used was preheated 0.1 N. HCl at 37 ± 2 0C. 
In-Vitro Drug release: 
Dissolution studies were performed in 900ml of 0.1N HCl 
(pH 1.1) using USP Dissolution Testing Apparatus II 
(Paddle type), at 50rpm and 37 ± 0.5 ◦C (Tablet 
Dissolution Test Apparatus, Veego / VDA – 6D USP 
standards). The amount of drug released over time was 
determined by withdrawing samples at various determined 
time intervals for 24 hrs and were replaced with fresh 
dissolution medium. The aliquots were filtered through 
Whatman filter paper Grade-1and concentration of drug 
was obtained by measuring the absorbance at 241 nm, in 
UV-visible spectrophotometer (Shimadzu UV - 1800). 
RESULTS: 
Authentification of Basil Seeds: 
The Samples of Ocimum basilicum seeds were 
authenticated by Botanical Survey of India, Pune with 
sample code No. BSI/ WC/ Tech. / 2012/ 624 and was 
found to be Ocimum basilicum L var. thyrsiflorum (L.) 
Benth. Family: Lamiaceae. 
Mucilage extraction from basil seeds: 
The yield of the mucilage was between 12-14%w/w on 
extraction from seeds. The yield was found to improve 
with the use of High speed homogenizer than by using 
simple stirrer or mortar and pestle (for separation of 
mucilage from seeds). 
Viscosity measurement of OBM: 
From viscosity study figure (1) it can be said that OBM 
system is shear thinning system. Because from graph it is 
clear that as shear rate increases the viscosity decreases. 
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Figure 1 Graph of Viscosity (cps) Vs Shear Rate (S-1) 
Spray drying of OBM: 
For spray drying various parameters were selected by trial 
and error. Main parameters which affected the yield and 
nature of product were inlet temperature, feed pump rate, 
and atomization pressure. 
Parameters for optimized batch were found to be: 
a) Inlet temperature: 220 °C  
b) Outlet temperature: 100 °C  
c) Inlet high: 240 °C  
d) Outlet high: 180 °C  
e) Aspirator flow rate: 45 Nm3/hr  
f) Feed pump rate: 8 ml/min  
g) On - Deblocking on: 1 sec  
h) On – Deblocking off: 10 sec  
i) Atomization pressure: 2.5 Kg/m2  
Spray drying improved the flow and compressional 
properties of the powder blend. 
Determination Water absorption capacity (WAC): 
Water absorption capacity was found to high 100.5. 
Effect of pH on WAC: 
The pH of mucilage solution was found to 7.24. WAC in 
0.1 N. HCl (pH 1.1) and 0.1 N. NaOH (pH 13) was found 
to be 95.6 and 97.6 respectively. 
Morphological analysis using Scanning Electron 
Microscope (SEM): 
Spray drying improved the morphological characteristics 
of particles with smaller particle size of around 4 – 5 μm, 
uniform spherical in shape having smooth surface. Based 
on the analysis of scanning electron microscopy the OBM 
dried in oven (figure 2) showed large particle size of 
around 100µm with rough surface, non-uniform shape. 
After spray drying the OBM powder SEM images showed 
particles with smaller particle size of around 4-5 µm was 
uniform in appearance, due to spherical particles flow 
property and  matrix forming property improved, tablets 
were intact with less friability and sustained their floating 
efficiency for more than 20 hrs. 
 
 
Figure 2: SEM Image of OBM Simple and Spray dried 
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Drug - excipient compatibility study: 
Figure (3c) DSC spectra of Spray dried mucilage showed 
the broad endothermic peak at 124.8 0C. Broad 
endothermic peak in DSC curve indicates the 
crystallization of the polymers as well as evaporation of 
water in the sample of polymer and decomposition of side 
chain.19, 20 
The endotherm obtained from the mixture figure (3b) 
showed characteristic peaks at 97.10C and 160.50C, as that 
of present in the standard DSC spectra of pure drug sample 
Figure (3a).  
Figure (4A) IR spectrum indicated characteristic peaks 
belonging to major functional groups such as principal 
peaks at wavenumbers 2924 and 3342 cm−1 shows 
presence of –OH and -CH stretching as mostly observed in 
polymers. An IR spectrum (figure 4B) shows that there 
was no drastic change in the peaks when compared with 
pure drug IR spectra. It clearly indicated that there was no 
interaction of drug with excipients. 
Precompression Parameters  
The precompression parameters were evaluated and were 
observed in the limit of good to passable flowability for 
most of the formulations as per IP specifications (Table 2).
 
 
Figure 3: Differential Scanning Calorimetry 
 
Figure 4: IR spectra A) Carvedilol Phosphate B) Physical Mixture of Drug and Polymer. 
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Table 2: Precompression parameters of powder blend prepared for floating layer 
Formulation 
Code 
Bulk Density (gm/cc) 
Tap Density 
(gm/cc) 
Hausner’s Ratio 
Compressibility 
Index (%) 
Angle of Repose 
(Degrees) 
 
Floating  Sustain Floating  Sustain Floating  Sustain Floating  Sustain Floating  Sustain 
F1 0.43 0.38 0.53 0.45 1.23 1.18 18.57 15.38 35.48 37.71 
F2 0.42 0.38 0.55 0.44 1.31 1.15 23.61 12.82 40.43 41.29 
F3 0.41 0.38 0.55 0.42 1.33 1.11 24.66 10.13 36.78 38.63 
F4 0.40 0.38 0.56 0.46 1.39 1.23 28.00 18.75 38.67 31.78 
F5 0.41 0.39 0.55 0.45 1.33 1.15 24.66 13.16 37.36 36.88 
F6 0.41 0.39 0.56 0.46 1.37 1.18 27.03 15.58 36.71 39.63 
F7 0.44 0.37 0.53 0.46 1.19 1.25 16.18 19.75 34.29 35.79 
F8 0.44 0.38 0.54 0.47 1.21 1.22 17.65 17.95 31.70 35.22 
F9 0.38 0.35 0.54 0.45 1.39 1.28 28.21 22.09 39.59 34.01 
F10 0.39 0.38 0.53 0.45 1.33 1.18 25.00 15.19 38.25 34.49 
F11 0.39 0.41 0.56 0.45 1.41 1.10 28.95 9.46 37.44 30.72 
F12 0.43 0.39 0.52 0.45 1.21 1.15 17.14 13.16 34.73 35.46 
F13 0.42 0.39 0.52 0.45 1.22 1.13 18.31 11.84 36.03 35.62 
F14 0.41 0.38 0.54 0.45 1.30 1.18 23.29 15.38 37.88 37.54 
F15 0.43 0.39 0.54 0.46 1.23 1.17 18.84 14.47 34.98 35.95 
F16 0.38 0.38 0.55 0.45 1.42 1.16 29.49 14.10 41.64 37.54 
 
Post compression parameters: 
In the evaluation of prepared tablet hardness was found to 
decrease with higher mucilage concentration it was in the 
range of 4.5 to 9.5kg/cm2. Whereas friability was within 
limits for all the formulations (0.16%-0.47%). And other 
parameters like thickness, weight variation, and content 
uniformity were found to be in limits as per table 3. 
The Bioadhesive force or detachment stress was an 
important physicochemical parameter to measure as the 
used hydrophilic polymers are of bioadhesive nature. 
During study it was observed that as the concentration of 
bioadhesive polymers increased the bioadhesive force 
increased significantly. All formulations showed 
bioadhesive force in the range of 4 × 103 to 10 × 103 
dynes/cm2. 
Table 3: Post compression parameters for bilayer tablets 
Formulation 
Code 
Thickness 
(mm) 
Hardness 
(kg/cm
2
) 
Friability (%) 
Weight 
variation (mg) 
Content 
Uniformity (%) 
DETACHMENT 
STRESS 
(dynes/sec
2
) 
F1 1.83 ± 0.014 4.5 ± 0.71 0.36 300.26 ± 0.84 99.26 ± 0.02 6326.58 
F2 1.77 ± 0.016 6.25 ± 0.35 0.47 299.75 ± 0.37 100.14 ± 0.21 8924.35 
F3 1.77 ± 0.013 9 ± 0.71 0.24 301.06 ± 0.61 100.31 ± 0.16 6436.04 
F4 1.81 ± 0.018 8.5 ± 0.71 0.32 299.38 ± 0.57 99.92 ± 0.27 7983.02 
F5 1.77 ± 0.021 8.5 ± 0.71 0.37 300.12 ± 1.06 99.21 ± 0.34 8041.4 
F6 1.79 ± 0.035 7 ± 0.71 0.21 301.22 ± 0.52 100.32 ± 0.17 4983.91 
F7 1.84 ± 0.00 5.25 ± 0.35 0.34 300.24 ± 0.73 100.06 ± 0.19 4772.3 
F8 1.82 ± 0.013 6.25 ± 0.35 0.26 301.32 ± 1.26 100.74 ± 0.41 5268.5 
F9 1.85 ± 0.007 4.25 ± 0.35 0.53 300.19 ± 0.79 99.64 ± 0.25 9252.72 
F10 1.75 ± 0.007 8 ± 0.71 0.38 300.41 ± 0.68 100.22 ± 0.10 7902.76 
F11 1.72 ± 0.009 9.5 ± 0.71 0.16 301.08 ± 0.55 99.47 ± 0.29 4407.45 
F12 1.83 ± 0.00 8.5 ± 0.72 0.24 300.81 ± 0.32 99.51 ± 0.36 7092.78 
F13 1.80 ± 0.006 8.5 ± 0.71 0.33 299.34 ± 0.63 99.62 ± 0.17 8216.53 
F14 1.85 ± 0.014 5.5 ± 0.74 0.28 300.27 ± 0.31 99.38 ± 0.08 7545.2 
F15 1.77 ± 0.021 8.25 ± 0.35 0.26 300.54 ± 0.41 99.38 ± 0.32 6290.1 
F16 1.82 ± 0.022 7.5 ± 0.71 0.41 300.09 ± 0.19 99.28 ± 0.14 7866.27 
 
Figure 5: Comparison between floating lag time and floating duration.TIF 
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The floating lag time and the total floating time: 
The floating layer composition was selected based on the 
lag time and the buoyancy time of the floating layer. The 
optimum concentration of sodium bicarbonate 
incorporated in the floating layer was 30mg (F1), from 
figure (5). The sustained release layer was optimized 
based on its duration of floatation and In-vitro drug 
release pattern. 
Swelling Characteristics: 
The percent swelling or swelling index data were 
subjected to the Vergnaud model to determine the rate of 
swelling of the formulations. The generalized form of 
the Vergnaud model is as follows: 
Mt = k t
n 
Where, 
Mt - The amount of liquid transferred at time (t). 
k - Swelling constant which depends on the amount of 
liquid transferred after infinite time, the porosity of 
matrix and diffusivity. 
n - The exponent indicates the mechanism of water 
uptake. 
By using swelling polymers and gas-generating agent, 
stable persistent floatation was obtained. As shown in 
the plot of resultant weight versus time in Figure (6), the 
bilayer tablets generated floating force of around 146.2 
after 10 hrs for formulation F7. The generated force was 
strong enough for the whole tablet to maintain on the 
surface of dissolution medium for as long as 20 hrs. All 
the formulations had the same composition in the 
floating layer, but different sustained release layer 
composition for each formulation might have brought 
the difference in the resultant weights for various 
formulations. The swelling index data fitted in the model 
with the value of exponent, n, in the range of 0.59 – 
0.79. (Table 4) 
 
Table 4 Kinetic values for Vergnaud’s equation 
Formulation 
code 
Kinetic 
constant 
(k) 
Swelling 
exponent 
(n) 
correlation 
coefficient 
(r2) 
F1 10.1833 0.7034 0.9845 
F2 9.1975 0.6686 0.9823 
F3 8.2022 0.6556 0.9943 
F4 9.6675 0.6111 0.9801 
F5 3.5381 0.787 0.928 
F6 9.8399 0.6734 0.9812 
F7 13.4439 0.6323 0.9918 
F8 11.2838 0.5957 0.9946 
F9 8.7263 0.6554 0.952 
F10 7.9072 0.6705 0.9691 
F11 5.6447 0.7297 0.9765 
F12 11.3831 0.6415 0.9884 
F13 10.3733 0.6189 0.9939 
F14 11.3749 0.6239 0.9882 
F15 10.0894 0.6457 0.9948 
F16 7.49 0.6991 0.944 
 
 
Figure 6: Graph of resultant weight vs. time for bilayer tablets 
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In-Vitro Drug release: 
In-vitro drug release was evaluated for all the 
formulations. The formulations were grouped depending 
on their duration of floatation into four groups i.e. those 
formulations had duration of floatation of around 22, 20, 
18, 14hrs, then release was compared with each other and 
marketed extended release formulation drug release profile 
(figure 7). 
 Group 1st – Duration of floatation 22hrs. – F2, F4, 
F7, F9, F15 
 Group 2nd – Duration of floatation 20hrs. – F13, 
F14, F16 
 Group 3rd – Duration of floatation 18hrs. – F3, F5, 
F8, F10, F12 
 Group 4th – Duration of floatation 14hrs. – F1, F6, 
F11 
From the In-vitro drug release data kinetic values were 
determined and found the best suited model for drug 
release mechanism. Kinetic analysis of drug release  table 
5 shows that the formulation F1, F3, F6, F9, F10, F11, 
F14, F15 follows Higuchi model for drug release and 
formulation F2, F4, F5, F7, F8, F12, F13 follows 
Korsmeyer – Peppas model and drug released by non – 
fickian mechanism as the value of n is within limit of 0.45 
– 0.89. 
Table 5: Kinetic analysis of dissolution study 
FORMU- 
LATION 
CODE 
% CDR 
ZERO ORDER FIRST ORDER 
KORSMEYER- 
PEPPAS MODEL 
HIGUCHI 
MODEL 
HIXSON- 
CROWEL 
MODEL 
K r
2
 K r
2
 n r
2
 K r
2
 K r
2
 
F1 98.19 ± 0.61 0.10 0.9374 0.002 0.60 0.67 0.9767 3.27 0.9921 0.004 0.9606 
F2 71.66 ± 0.99 0.05 0.9747 0.001 0.65 0.58 0.9971 1.91 0.9820 -0.001 0.9907 
F3 84.94 ± 0.98 0.07 0.9451 0.001 0.66 0.63 0.9863 2.50 0.9868 -0.002 0.9815 
F4 93.80 ± 0.38 0.06 0.9415 0.001 0.59 0.57 0.9935 2.36 0.9931 -0.002 0.9693 
F5 84.32 ± 0.42 0.07 0.9792 0.001 0.67 0.63 0.9978 2.48 0.9790 -0.002 0.9795 
F6 95.70 ± 0.20 0.10 0.9311 0.002 0.63 0.67 0.9866 3.26 0.9953 -0.003 0.9766 
F7 74.69 ± 0.52 0.05 0.8204 0.001 0.53 0.61 0.9880 2.10 0.9563 -0.001 0.8846 
F8 79.54 ± 0.20 0.06 0.8707 0.001 0.56 0.62 0.9848 2.36 0.9795 -0.002 0.9396 
F9 63.68 ± 0.36 0.04 0.9382 0.001 0.52 0.72 0.9823 1.70 0.9992 -0.001 0.9733 
F10 82.23 ± 0.35 0.06 0.9370 0.001 0.55 0.70 0.9860 2.42 0.9954 -0.002 0.9860 
F11 98.68 ± 0.29 0.12 0.9095 0.002 0.58 0.85 0.9682 3.72 0.9846 -0.005 0.9374 
F12 76.85 ± 1.13 0.06 0.9515 0.001 0.64 0.61 0.9983 2.23 0.9960 -0.001 0.9883 
F13 71.05 ± 0.26 0.05 0.9724 0.002 0.57 0.69 0.9935 2.14 0.9803 -0.001 0.9926 
F14 80.91 ± 1.48 0.06 0.9111 0.002 0.40 1.22 0.9282 2.33 0.9907 -0.001 0.9709 
F15 87.82 ± 0.99 0.06 0.9283 0.001 0.43 1.04 0.9422 2.36 0.9971 -0.002 0.9851 
F16 67.53 ± 0.39 0.05 0.9302 0.001 0.64 0.60 0.9936 1.97 0.9933 -0.001 0.9689 
 
Only the prepared formulations which shown floating 
ability for more than 20 hrs was considered as suitable 
formulations. So, drug release profiles of these 
formulations were compared with the marketed extended 
release formulation drug release profile table 6. From all 
the formulations F4 shown the highest similarity factor 
66.14, lowest difference factor 6.58, and least value for 
Rascigno index (ξ1 = 0.0328, ξ2 = 0.0349) which revealed 
F4 was the optimised formulation which satisfies all the 
requirements. 
 
Table 6: Parameters for release profile comparison 
FORMULATION 
CODE 
f’1 
VALUE 
f2 
VALUE 
RASCIGNO 
INDEX 
  
(ξ1) i=1 (ξ2) i=2 
F2 35.68 35.17 0.1784 0.1688 
F4 6.58 66.14 0.0328 0.0349 
F7 15.01 46.64 0.0751 0.0904 
F9 38.56 32.77 0.1927 0.1926 
F15 7.2 63.49 0.036 0.0436 
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Figure 7: Graph showing drug release profile of bilayer tablet formulations 
DISCUSSION: 
Our aim was to use natural polymers in formulation to 
minimize the proportion of synthetic polymers and to 
study the effect of polymer and Mucilage concentrations 
on floating duration and drug release.  
For this first primary evaluations were done for mucilage. 
As per Farhoosh R. et al.21 at low shear rate, mucilage 
molecules are disarranged and only partially aligned, 
resulting in a high viscosity and with increase shear rate, 
the molecules become oriented and aligned, thus resulting 
in a decrease in inner friction and lower viscosity. It was 
also found that with increasing concentration of mucilage 
solution there was increase in viscosity of OBM. 
According to Vardhanabhuti et.al.22 linear and stiff 
molecules have a large hydrodynamic size, which 
contributes to high viscosity and pseudoplasticity in 
mucilage solution. This could be due to the polar hydroxyl 
groups in the mucilage and hence their extent of 
hydrodynamic interaction. 
The higher value of WAC at neutral pH may be related to 
molecular chains which remain in a close to the rod 
conformation in the solution. In more alkaline regions it 
may possible that alkaline depolymerization reactions 
show lower WAC. And in lower pH charge suppression 
results in a smaller conformation of the polymer chains 
because of acidic components exist in the free acid form 
which may result in lower WAC compared to neutral 
conditions. As the water absorption capacity and Viscosity 
was very high the mucilage is a good candidate for the 
floating and sustaining drug release.  
Firstly the experiment was performed with simple OBM, 
but the problems occurred as early disintegration of tablets 
in 2-3 hrs, more friable tablets due to poor matrix forming 
ability, poor flow property, non uniform mixing with 
powder blend because of low density and non uniform 
appearance of tablets. From morphological study it is clear 
that the surface properties were improved after Spray 
dying than that of simple form.  
Floating layer was separately prepared to avoid any 
interference of the alkaline sodium carbonate in the release 
of drug. HPMC – K 100 M showed better floating 
capabilities due to greater molecular weight and  has the 
fastest rate of hydration due to the hydrophobic and 
hydrophilic substituents i.e. methoxyl group and 
hydroxypropyl group on it. OBM was used as filler, binder 
due to its ability to swell and gel. When used with HPMC 
and Sodium bicarbonate due to high viscosity of the 
mucilage and HPMC, CO2 gas is entrapped within the 
swollen structure and increases the buoyancy of the 
formulation and also helped to decrease the lag time.  
In order to get shorter lag time increasing concentration of 
effervescent mixture was used, and it was observed that at 
higher concentration floating layer dispersed where as at 
lower concentration of 20mg lag time was prolonged. 
The second layer (sustained release layer) provided control 
release of active material and contains drug, HPMC K100 
M as a hydrophilic matrix material. OBM was used as 
release retardant due to its swelling, gelling ability and 
MCC was added as diluent. An attempt was made to 
reduce the concentration of HPMC’s which is costlier, by 
combining them with OBM to achieve the desired 
sustained release pattern.  
A value of ≤ 0.5 for n  in the swelling index data indicates 
a diffusion-controlled mechanism in which the rate of 
diffusion of the liquid is much less as compared with the 
rate of relaxation of the polymer segment. A value of one 
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for n (n=1) suggests that the stress relaxation process is 
very slow as compared with the rate of diffusion. This 
means that the liquid diffuse through the polymer matrix at 
a constant velocity showing an advancing front marking 
the limit of liquid penetration. Behind this front is swollen 
gel and ahead of it is the polymer in the glassy state. A 
value of n between 0.45 and 1 indicates an anomalous or 
complex behaviour in which the rate of diffusion of the 
liquid and that of relaxation are of the same magnitude. 
According to this the matrices having n value between 
0.59 – 0.79 follows diffusion and stress relaxation 
mechanism, and shows anomalous or complex behaviour, 
the liquid diffuses through the polymer matrix at a constant 
velocity, and the rate of diffusion of the liquid and that of 
stress relaxation of the polymer are almost of the same 
magnitude.6The resultant weight force is responsible for 
floating and depends upon the the weight and the floating 
forces. As the water gets absorbed into the matrix, weight 
of matrix increases and compensated by swelling in order 
to keep the dosage form in floating state.  
The dissolution kinetics showed results similar to that 
obtained from of Vergnaud model, the non-fickian drug 
release from the tablet dissolution data, which confirmed 
the mechanism of drug release. Also the similarity factor is 
a logarithmic reciprocal square root transformation of the 
sum of squared 
error and is a measurement of the similarity in the percent 
dissolution between the two curves23. This model 
independent method is most suitable for dissolution profile 
comparison between marketed and optimized formulation, 
therefore values showing highest similarity factor, least 
difference factor indicate the formulation to be the best 
formulation. 
CONCLUSION: 
From the results it was concluded that the prepared 
floating bilayer matrix tablet would be the better choice for 
Carvedilol phosphate than other conventional sustained 
release dosage forms as it provides drug in a soluble form 
to its site of absorption for 24 hrs which may result in 
increase of bioavailability of drug. At the same time the 
natural polymers such as spray dried OBM has proved to 
have a great potential for usage in the gastroretentive 
dosage forms as a swelling and Sustaining polymer, and 
when used in combination with synthetic polymers shows 
good matrix forming properties with better control on 
release rate of drug from matrix. 
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